Taken together, our data suggest that urinary Gal-3 may be a useful biomarker for the identification of individuals at risk of kidney disease progression and those predisposing to renal fibrosis, which may contribute to the pathogenesis of CKD early in the disease course. Here, LGALS3 is linked to kidney disorder.